Bausch Health Companies | VRX - Ordinary Share Capital


Bausch Health Companies reported $373.9M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Amgen USD 541M 1000K Jun/2026
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Aurora Cannabis CAD 58.95M 2.24M Mar/2026
Bausch Health Companies USD 373.9M 436K Jun/2026
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 422.07M 53.78M Mar/2026
Corcept Therapeutics USD 107.33M 1.36M Mar/2026
Danaher USD 702.9M 4.8M Jun/2026
Drreddys Laboratories INR 832.69M 123K Mar/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Gilead Sciences USD 1.24B 1000K Jun/2026
Nektar Therapeutics USD 29.47M 9.09M Mar/2026
Novo Nordisk DKK 4.43B 13.25M Jun/2026
Pacira USD 39.82M 512K Jun/2026
Perrigo USD 138.1M 500K Mar/2026
Phibro Animal Health USD 40.48M 0 Dec/2025
Prestige Brands USD 47.32M 765K Dec/2025
Supernus Pharmaceuticals USD 58.16M 124K Jun/2026
Vertex Pharmaceuticals USD 253.3M 900K Jun/2026
Zoetis USD 420.35M 4.58M Mar/2026